https://clinicaltrials.gov/ct2/show/NCT03958877?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Condition : Multiple Sclerosis, Relapsing-Remitting
Interventions : Drug: BIIB017 (peginterferon beta-1a); Drug: Interferon beta type 1a
Sponsor : Biogen
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
NCT03958877
Wed, 22 May 2019 12:00:00 EDT
First Added: 05/22/19 07:41AM